Home Newsfeeds Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.

byBenzinga Newsdesk

December 12, 2022

1 minute read

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.

KBH Downgraded: Goldman Sachs Points Out Spike In Cancellation Rates And Debt Concerns

By Lekha Gupta

October 16, 1:19 PM

Goldman Sachs analyst Susan Maklari downgraded KB Home (NYSE: KBH) to Neutral from Buy at a lowered

KBH

Netflix Crashes As ‘Stranger Things 4’ Volume 2 Goes Live: Was Vecna To Blame?

By Phil Hall

July 1, 10:19 AM

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

DIS

Morgan Stanley Maintains Overweight on Allegiant Travel, Lowers Price Target to $237

By Benzinga Newsdesk

July 8, 7:48 AM

Morgan Stanley analyst Ravi Shanker maintains Allegiant Travel (NASDAQ:ALGT) with a Overweight and lowers the price target from $250 to $237.

ALGT

Oxford Industries Adds This Luxury & Modern Bohemian Brand; Boosts Outlook

By Shivani Kumaresan

September 20, 7:14 AM

Oxford Industries Inc (NYSE:OXM) has completed the acquisition of Johnny Was, a California-based affordable luxury apparel brand, for $270 million.…

OXM

Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Related Posts

KBH Downgraded: Goldman Sachs Points Out Spike In Cancellation Rates And Debt Concerns

Netflix Crashes As ‘Stranger Things 4’ Volume 2 Goes Live: Was Vecna To Blame?

Morgan Stanley Maintains Overweight on Allegiant Travel, Lowers Price Target to $237

Oxford Industries Adds This Luxury & Modern Bohemian Brand; Boosts Outlook